The U.S. Food and Drug Administration is reviewing whether to change the warning label on hormone replacement therapy drugs ...

The U.S. Food and Drug Administration said on Friday that it has launched a new pilot program to speed up the review process ...

Drug manufacturers who test and produce their generic medicines on US soil will now have access to priority review.

This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S.

Following up on previous, dimly received issuances, a new set of ideas published by the FDA to streamline regulatory pathways ...

U.S. Health Secretary Robert F Kennedy Jr. could deliver a policy win for the Trump administration in just a few months after ...

Pfizer is the first of many drug makers President Trump claimed has agreed to offer steep drug discounts to all Americans ...

The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for ...